A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients
Clinical trial NCT03239691 · COMPLETED
Trial details
- NCT number
- NCT03239691
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-06
- Primary completion
- 2018-04-25
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.